Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Lilly glycopeptide antibiotic compared to vancomycin and teicoplanin in vitro

March 2, 1998

Pharmacodynamics of HMR-3647 against respiratory pathogens, enterococci and B. fragilis

March 2, 1998

Novel antiviral agents from Lilly

March 2, 1998

Patent coverage for ProLease interferon

Feb. 27, 1998

Beta-lactams with dual beta-lactamase-inhibitory/antibacterial activity from Roche

Feb. 27, 1998

Biosearch Italia and Versicor establish infectious disease collaboration

Feb. 25, 1998

New herpes collaboration between Astra and Medivir

Feb. 24, 1998

Floxin Otic launched in U.S.

Feb. 24, 1998

Clinical status of CS-834

Feb. 23, 1998

Idec RSV antibodies covered by U.S. patents; development partners sought

Feb. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.